Neurothera Labs Inc (NTLX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 01/31
(Values in thousands)
| 07-2025 | 04-2025 | 01-2025 | 10-2024 | 07-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,047 | 1,073 | 1,079 | 1,095 | 1,120 |
| Receivables | 1 | N/A | N/A | N/A | N/A |
| TOTAL | $1,048 | $1,074 | $1,081 | $1,096 | $1,121 |
| Non-Current Assets | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $1,048 | $1,074 | $1,081 | $1,096 | $1,121 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 122 | N/A | 6 | N/A | N/A |
| Accrued Expenses | 35 | N/A | 150 | N/A | N/A |
| TOTAL | $156 | $165 | $156 | $12 | $47 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $156 | $165 | $156 | $12 | $47 |
| Shareholders' Equity | |||||
| Common Shares | 1,481 | 1,481 | 1,481 | 1,481 | 1,481 |
| Retained earnings | -631 | -613 | -598 | -438 | -449 |
| Other shareholders' equity | 42 | 42 | 42 | 42 | 42 |
| TOTAL | $892 | $909 | $925 | $1,084 | $1,074 |
| Total Liabilities And Equity | $1,048 | $1,074 | $1,081 | $1,096 | $1,121 |